Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
123.77
+6.49 (5.53%)
At close: Jun 26, 2026, 4:00 PM EDT
122.44
-1.33 (-1.07%)
After-hours: Jun 26, 2026, 6:13 PM EDT
Mirum Pharmaceuticals Stock Forecast
Stock Price Forecast
The 14 analysts with 12-month price forecasts for Mirum Pharmaceuticals stock have an average target of 145.36, with a low estimate of 115 and a high estimate of 185. The average target predicts an increase of 17.44% from the current stock price of 123.77.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Mirum Pharmaceuticals stock from 14 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 8 | 8 | 9 | 10 |
| Buy | 2 | 3 | 3 | 3 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 11 | 11 | 11 | 13 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Maintains $150 | Buy | Maintains | $150 | +21.19% | Jun 15, 2026 |
| Citi | Citi | Buy Maintains $145 | Buy | Maintains | $145 | +17.15% | Jun 15, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $185 | Buy | Reiterates | $185 | +49.47% | Jun 15, 2026 |
| Citizens JMP | Citizens JMP | Buy Maintains $140 → $146 | Buy | Maintains | $140 → $146 | +17.96% | Jun 15, 2026 |
Unknown Analyst J.P. Morgan No rating | J.P. Morgan | Buy Initiates $115 | Buy | Initiates | $115 | -7.09% | May 20, 2026 |
Financial Forecast
Revenue This Year
675.30M
from 521.31M
Increased by 29.54%
Revenue Next Year
814.44M
from 675.30M
Increased by 20.60%
EPS This Year
-16.33
from -0.47
EPS Next Year
-0.09
from -16.33
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 683.4M | 896.6M | |
| Avg | 675.3M | 814.4M | |
| Low | 669.0M | 712.4M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 31.1% | 32.8% | |
| Avg | 29.5% | 20.6% | |
| Low | 28.3% | 5.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -16.33 | 0.70 | |
| Avg | -16.33 | -0.09 | |
| Low | -16.33 | -1.24 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.